The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists

Psychopharmacology

Volumn 148, Issue 2, 2000, Pages 153-163

  El Yacoubi, Malika ^a   Ledent, Catherine ^b   Parmentier, Marc ^b   Costentin, Jean ^a   Vaugeois, Jean Marie ^a  

^a UFR de Medécine Pharmacie   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

A(2A) receptor knockout; A1 receptor; Adenosine; Light dark test; Plus maze test; SCH58261; ZM241385

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; CAFFEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LONG TERM EXPOSURE; MALE; MAZE TEST; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; STRAIN DIFFERENCE; TASK PERFORMANCE;

EID: 0009267815     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050037     Document Type: Article

References (68)

1. Baldwin HA, File SE (1989) Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav 32:181-186
2. Baldwin HA, Johnston AL, File SE (1989) Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol 159:211-215
3. Baumgold J, Nikodijevic O, Jacobson KA (1992) Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol 43:889-894
4. Berthou F, Guillois B, Riche C, Dreano Y, Jacqz-Aigrain E, Beaune Ph (1992) Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22:671-680
5. 2A adenosine receptors on sleep-waking patterns in rats. Drug Dev Res 37:65-72
6. Bhattacharya SK, Satyan KS, Chakrabarti A (1997) Anxiogenic action of caffeine: an experimental study in rats. J Psychopharmacol 11:219-224
7. Blumstein LK, Crawley JN (1983) Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 18:37-40
8. Boulenger JP, Uhde TW, Wolff EA, Post RM (1984) Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiatry 41:1067-1071
9. Boulenger JP, Salem N Jr, Marangos PJ, Uhde TW (1987) Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine. Psychiatry Res 21:247-255
10. Brett RR, Pratt JA (1990) Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze. Eur J Pharmacol 178:135-138
11. Bruce MS (1990) The anxiogenic effects of caffeine. Postgrad Med J 66:S18-S24
12. 1-mediated hemodynamic effects. J Pharmacol Exp Ther 268:1506-1511
13. Charney DS, Heninger GR, Jatlow PI (1985) Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42:233-243
14. Choi OH, Shamim MT, Padgett WL, Daly JW (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci 43:387-398
15. Commissaris RL, McCloskey TC, Damian GM, Brown BD, Barraco RA, Altman HJ (1990) Antagonism of the anti-conflict effects of phenobarbital, but not diazepam, by the A-1 adenosine agonist L-PIA. Psychopharmacology 102:283-290
16. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777-785
17. 2A gene to the development of disease. Mol Psychiatry 3:81-85
18. Durcan MJ, Morgan PF (1991) Hypothermic effects of alkylxanthines: evidence for a calcium-independent phosphodiesterase action. Eur J Pharmacol 204:15-20
19. Eaton WW, McLeod J (1984) Consumption of coffee or tea and symptoms of anxiety. Am J Public Health 74:66-68.
20. 1 receptor antagonists and agonists in mice (Abstract 205). Drug Dev Res 43:54
21. Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108:51-59
22. 2B receptors. Pharmacol Rev 49:381-401
23. File SE, Baldwin HA, Johnston AL, Wilks LJ (1988) Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol Biochem Behav 30:809-815
24. 1 receptors modulate anxiety in CDI mice. Psychopharmacology 136:311-319
25. Fredholm BB (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 76:93-101
26. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133
27. Greden JF (1974) Anxiety or caffeinism: a diagnostic dilemma. Am J Psychiatry 131:1089-1092
28. 1-selective antagonist, DPCPX. Psychopharmacology 103:541-544
29. Griebel G, Perrault G, Sanger DJ (1998) Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Psychopharmacology 138:55-66
30. Griffiths RR, Woodson PP (1988) Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther 246:21-29
31. 2 receptors in the striatum of the rat following chronic treatment with diazepam. Neuropharmacology 27:1131-1140
32. Heaslip RJ, Evans DY (1995) Emetic, central nervous system and pulmonary activities of rolipram in the dog. Eur J Pharmacol 286:281-290
33. Howell LL, Coffin VL, Spealman RD (1997) Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology 129:1-14
34. Imaizumi M, Miyazaki S, Onodera K (1994) Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors. Methods Find Exp Clin Pharmacol 16:639-644
35. Jacobson KA, van Rhee (1997) Development of selective purinoceptor agonists and antagonists. In: Jacobson KA, Jarvis MF (eds) Purinergic approaches in experimental therapeutics. Wiley-Liss, New York Chichester Weinheim Brisbane Singapore Toronto, pp 101-128
36. Jacobson KA, von Lubitz DKJE, Daly JW, Fredholm BB (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 17:108-113
37. Jain N, Kemp N, Adeyemo O, Buchanan P, Stone TW (1995) Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 116:2127-2133
38. Johansson B, Georgiev V, Kuosmanen T, Fredholm BB (1996) Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline-and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. Eur J Neurosci 8:2447-2458
39. 2A receptor agonists and antagonists. Neuroscience 85:229-237
40. 1 adenosine receptor occupancy. Neuropsychopharmacology 6:145-153
41. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI (1997) Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 37:693-703
42. Katims JJ, Annau Z, Snyder SH (1983) Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J Pharmacol Exp Ther 227:167-173
43. Kehr W, Debus G, Neumeister R (1985) Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain. J Neural Transm 63:1-12
44. 2A receptor. Nature 388:674-678
45. Lee MA, Flegel P, Greden JF, Cameron OG (1988) Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 145:632-635
46. Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, Simons MJ, Dumont JE, Vassart G (1989) Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science 244:569-572
47. 1 adenosine receptor. EMBO J 10:1677-1682
48. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185
49. 2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173:1169-1178
50. 1 receptors, using in vivo and in vitro techniques. J Pharmacol Exp Ther 285:1023-1030
51. Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17:139-170
52. Nickell PV, Uhde TW (1994-1995) Dose-response effects of intravenous caffeine in normal volunteers. Anxiety 1:161-168
53. 2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther 259:286-294
54. 2A adenosine receptor antagonist. Drug Dev Res 42:63-70
55. 2A receptors. Trends Pharmacol Sci 17:364-372
56. Ongini E, Dionisotti S, Gessi S, Fredholm BB (1999) Comparison of CGS 15943, ZM241385 and SCH58261 as antagonists at human adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 359:7-10
57. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
58. 2A selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102
59. Sawynok J (1998) Adenosine receptor activation and nociception. Eur J Pharmacol 347:1-11
60. Snyder SH (1997) Knockouts anxious for new therapy. Nature 388:624
61. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260-3264
62. Stern KN, Chait LD, Johanson CE (1989) Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology 98:81-88
63. Stiles GL (1997) Adenosine receptor subtypes: new insights from cloning and functional studies. In: Jacobson KA, Jarvis MF (eds) Purinergic approaches in experimental therapeutics. Wiley-Liss, New York Chichester Weinheim Brisbane Singapore Toronto, pp 29-37
64. Svenningsson P, Nomikos CG & Fredholm BB (1995) Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci 15:7612-7624
65. Treit D (1994) Animal models of anxiety and anxiolytic drug action. In: den Boer JA, Ad Sitsen JM (eds) Handbook of depression and anxiety: a biological approach (Medical Psychiatry series, vol 1). Marcel Dekker, New York Basel Hong Kong, pp 201-224
66. Uhde TW, Boulenger JP, Jimerson DC, Post RM (1984) Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacol Bull 20:426-430
67. van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999-1005
68. Wachtel H (1982) Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′, 5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology 77:309-316